Al Said Aly, MD | |
200 S Manchester Ave, 650, Orange, CA 92868-3217 | |
(714) 456-5253 | |
(714) 456-7718 |
Full Name | Al Said Aly |
---|---|
Gender | Male |
Speciality | Plastic And Reconstructive Surgery |
Experience | 41 Years |
Location | 200 S Manchester Ave, Orange, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154476588 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2086S0122X | Surgery - Plastic And Reconstructive Surgery | A41700 (California) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Texas Southwestern Medical Center | 0648188250 | 2588 |
News Archive
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
The University of North Carolina at Chapel Hill is one of twelve centers announced today by President Obama as part of an unprecedented large-scale, collaborative effort by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer.
› Verified 8 days ago
Entity Name | University Of Texas Southwestern Medical Center At Dallas |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972579365 PECOS PAC ID: 0648188250 Enrollment ID: O20031106000792 |
News Archive
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
The University of North Carolina at Chapel Hill is one of twelve centers announced today by President Obama as part of an unprecedented large-scale, collaborative effort by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Al Said Aly, MD 2236 Martin Dr, Tustin, CA 92782-1033 Ph: (714) 389-9689 | Al Said Aly, MD 200 S Manchester Ave, 650, Orange, CA 92868-3217 Ph: (714) 456-5253 |
News Archive
Following on from a successful world's first Phase I gene therapy trial for choroideremia, Professor Robert MacLaren and his team at Oxford University and the Oxford Eye Hospital at the John Radcliffe Hospital have started a Phase II trial enrolling 30 patients.
Researchers from Purdue and Stony Brook universities have determined the precise atomic-scale structure of the poliovirus attached to key receptor molecules in human host cells and also have taken a vital snapshot of processes leading to infection.
Urodynamix Technologies Ltd. (TSX VENTURE:URO) today reported its financial results for its fiscal second quarter ended June 30, 2009. The Company reported revenues of $21,871, a 70% decrease over the same quarter of the prior year. The Company's order backlog at June 30, 2009 was $92,576 compared to nil at the end of the comparative quarter June 30, 2008.
The University of North Carolina at Chapel Hill is one of twelve centers announced today by President Obama as part of an unprecedented large-scale, collaborative effort by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to systematically characterize the genomic changes that occur in cancer.
› Verified 8 days ago
Xuan-binh D Pham, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 W La Veta Ave Ste 320, Orange, CA 92868 Phone: 714-598-1194 | |
Dr. Douglas Albert Brownell, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1140 W La Veta Ave Ste 850, Orange, CA 92868 Phone: 714-997-4961 Fax: 714-560-4455 | |
Dr. Eric Owen Yeates, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 101 The City Dr S, Orange, CA 92868 Phone: 714-456-7890 | |
Shray Malik, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 3800 W Chapman Ave Ste 6200, Orange, CA 92868 Phone: 714-456-6262 | |
John Clifford German, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 396 S Main St Ste 200, Orange, CA 92868 Phone: 714-361-4480 Fax: 714-361-4490 | |
Michael J Stamos, MD Surgery Medicare: Medicare Enrolled Practice Location: Uci Medical Center, 101 The City Drive South, Orange, CA 92868 Phone: 714-456-8978 | |
Dr. Eric James Kuncir, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 333 City Blvd W, Suite 1600, Orange, CA 92868 Phone: 714-456-5890 Fax: 714-456-6048 |